A carregar...

Emerging Therapies for Chronic Hepatitis C Virus

Current hepatitis C virus (HCV) therapies are associated with significant adverse events and less-than-ideal sustained virologic response (SVR) rates in genotype 1 patients. The current standard of care, a combination of pegylated interferon and ribavirin, will likely remain a key component of the t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Autor principal: Pockros, Paul J.
Formato: Artigo
Idioma:Inglês
Publicado em: Millennium Medical Publishing 2008
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3104185/
https://ncbi.nlm.nih.gov/pubmed/21960894
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!